Norway not only has a rich source of oil but has a rich supply of real world data sources (RWDs), especially when in concerns oncology!
Norway has a rich of real world data sources, which have been used for research and publications.
Real-world evidence (RWE) has often been discussed in the pharmaceutical and medical technology fields as an emerging tool for assessing safety of new treatments.
The aim of our review is to uncover which real world datasets, based on patient / disease based registries, exist in Europe regarding atrial fibrillation .
Many medical device manufacturers have found themselves caught in a trap where there is a DRG and/or ZE (add-on payment) available for their technology but where the insurance companies refuse to pay this fee.
Subscribe to newsletter